Detalhe da pesquisa
1.
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials.
Br J Dermatol
; 190(5): 668-679, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226713
2.
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study.
J Am Acad Dermatol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554938
3.
Patterns and cost of care according to keratinocyte cancer risk stratification in a volunteer population screening clinic: Real-world data from the TRoPICS study.
Australas J Dermatol
; 64(3): 389-396, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092598
4.
Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.
Clin Exp Dermatol
; 47(6): 1144-1153, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150158
5.
Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study.
Australas J Dermatol
; 63(3): 312-320, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816576
6.
Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting.
Australas J Dermatol
; 63(4): 421-436, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125089
7.
Randomized, Placebo-Controlled Phase 1/2 Study to Determine the Appropriate ATX-101 Concentration for Reduction of Submental Fat.
Dermatol Surg
; 47(8): 1065-1070, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115682
8.
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Australas J Dermatol
; 62(2): 119-123, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32840870
9.
Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm2 on the chest: A phase 3 randomized controlled trial.
J Am Acad Dermatol
; 82(3): 642-650, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31374304
10.
Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
Acta Derm Venereol
; 100(1): adv00006, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31620802
11.
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
N Engl J Med
; 373(14): 1318-28, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26422722
12.
Safety and longevity of biological treatment in the setting of moderate-to-severe psoriasis: enhancing the body of evidence.
Br J Dermatol
; 188(6): 696, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005389
13.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
N Engl J Med
; 371(4): 326-38, 2014 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25007392
14.
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study.
J Am Acad Dermatol
; 76(6): 1093-1102, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28291552
15.
Debunking the Myth of Wool Allergy: Reviewing the Evidence for Immune and Non-immune Cutaneous Reactions.
Acta Derm Venereol
; 97(8): 906-915, 2017 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350041
16.
Squamous cell carcinoma and keratoacanthomas are biologically distinct and can be diagnosed by light microscopy: a review.
Histopathology
; 69(4): 535-41, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27323251
17.
Management of disseminated superficial actinic porokeratosis and intraepidermal squamous cell carcinoma with low-dose radiation therapy.
Australas J Dermatol
; 62(3): 410-412, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954983
18.
Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
Australas J Dermatol
; 57(1): 24-8, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25827200
19.
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
Australas J Dermatol
; 57(3): 167-74, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26033230
20.
Crisaborole Topical Ointment, 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study.
J Drugs Dermatol
; 14(10): 1108-12, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26461821